Asia Pacific Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country
Publication Month: Feb 2019
Report Code: TIPRE00003317 No. of Pages: 155 Category: Biotechnology Status: Published
The Asia Pacific human microbiome market is expected to reach US$ 207.81 Mn in 2025 from US$ 41.73 in 2017. The market is estimated to grow with a CAGR of 22.8% from 2018-2025.
The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of awareness about human microbiome science is likely to have a negative impact on the growth of the market in the coming years.
Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health. The Gut Health Congress was held in Hong Kong Asia in 2018, the conference explore in detail of diet & personalised nutrition, gastrointestinal microbiome and several case studies with regards to clinical studies, diagnostics studies, treatment methods, biomarker developments, molecular therapy and gastrointestinal diseases. Also, the 5th Microbiome R&D and Business Collaboration Congress was held in Taiwan, Asia in March 2019, the conference focused on recent developments in gut microbiome, skin microbiome, infant, women and oral health, therapeutics, microbiome and diet.
Also, many companies are designing and developing many microbiome therapies. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
Japan is anticipated to lead the adoptions of Human microbiome across the Asia Pacific region through the forecast period. Researchers from Japan are using the outcomes of studies on centenarians in the country to try and produce new products that will replicate the beneficial aspects of their microbiota. The goal of the collaboration is to solve few of the major technological hurdles in advancing stem cell research. Moreover, Cykinso (Tokyo) received the US$ 2.3 million (270 million yen) funds from the Regional Health Care Industry Support Fund, develop and sell Mykinso or a test kit for intestinal flora. The company plans to use the funds for business development purposes, which include using the data collected from the intestinal flora tests to develop a system for offering nutritional guidance. Thus, the investments and the initiatives taken by the government are likely to propel the growth of the market in the forecast period.
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Product
• Probiotics
• Foods
• Prebiotics
• Medical Foods
• Diagnostic Device
• Drugs
• Supplements
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Disease
• Obesity
• Diabetes
• Autoimmune Disorders
• Cancer
• Mental Disorders
• Others
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Application
• Therapeutics
• Diagnostics
By Country
• U.S.
• Canada
• Mexico
Companies Mentioned
• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Osel Inc.
• Vedanta Biosciences, Inc.
• Metabiomics Corporate
• Synthetic Biologics, Inc.
• DuPont
• BiomX Ltd.
The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of awareness about human microbiome science is likely to have a negative impact on the growth of the market in the coming years.
Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health. The Gut Health Congress was held in Hong Kong Asia in 2018, the conference explore in detail of diet & personalised nutrition, gastrointestinal microbiome and several case studies with regards to clinical studies, diagnostics studies, treatment methods, biomarker developments, molecular therapy and gastrointestinal diseases. Also, the 5th Microbiome R&D and Business Collaboration Congress was held in Taiwan, Asia in March 2019, the conference focused on recent developments in gut microbiome, skin microbiome, infant, women and oral health, therapeutics, microbiome and diet.
Also, many companies are designing and developing many microbiome therapies. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.
Japan is anticipated to lead the adoptions of Human microbiome across the Asia Pacific region through the forecast period. Researchers from Japan are using the outcomes of studies on centenarians in the country to try and produce new products that will replicate the beneficial aspects of their microbiota. The goal of the collaboration is to solve few of the major technological hurdles in advancing stem cell research. Moreover, Cykinso (Tokyo) received the US$ 2.3 million (270 million yen) funds from the Regional Health Care Industry Support Fund, develop and sell Mykinso or a test kit for intestinal flora. The company plans to use the funds for business development purposes, which include using the data collected from the intestinal flora tests to develop a system for offering nutritional guidance. Thus, the investments and the initiatives taken by the government are likely to propel the growth of the market in the forecast period.
Exhibit: Rest Of Asia Pacific Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Product
• Probiotics
• Foods
• Prebiotics
• Medical Foods
• Diagnostic Device
• Drugs
• Supplements
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Disease
• Obesity
• Diabetes
• Autoimmune Disorders
• Cancer
• Mental Disorders
• Others
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Application
• Therapeutics
• Diagnostics
By Country
• U.S.
• Canada
• Mexico
Companies Mentioned
• Enterome
• MicroBiome Therapeutics, LLC
• Rebiotix Inc.
• Yakult Honsha Co., Ltd.
• Osel Inc.
• Vedanta Biosciences, Inc.
• Metabiomics Corporate
• Synthetic Biologics, Inc.
• DuPont
• BiomX Ltd.
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Asia Pacific Human microbiome Market – Key takeaways
PART 3. Asia Pacific Human microbiome market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Asia Pacific Human Microbiome Market – By Product
3.2.2 Asia Pacific Human Microbiome Market – By Disease
3.2.3 Asia Pacific Human Microbiome Market – By Application
3.2.4 Asia Pacific Human Microbiome Market North America
3.3 PEST Analysis
3.3.1 Asia Pacific– PEST Analysis
PART 4. Asia Pacific HUMAN MICROBIOME market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Chronic Disease due to change in lifestyle
4.1.2 Growing interest in Human Microbiome Treatment approach
4.2 Key Market Restraints
4.2.1 Stringent regulatory environment
4.2.2 Lack of Awareness About Human Microbiome Science
4.3 Key Market Opportunities
4.3.1 Growing Initiatives To Raise The Awareness in Emerging Nations
4.4 future Trends
4.4.1 The Human Microbiome Drug Development Is Revolutionizing The Medical Industry
4.5 Impact analysis
PART 5. Human microbiome market – Asia Pacific Analysis
5.1 Asia Pacific Human microbiome market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
Enterome
Yakult Honsha Co., Ltd.
5.4 expert opinions
PART 6. Asia Pacific Human microbiome market Analysis – By Product
6.1 Overview
6.2 ASIA PACIFIC Human microbiome MARKET, BY product, 2017 & 2025 (%)
6.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
6.4 FOODS Market
6.4.1 Overview
6.4.2 Asia Pacific Foods Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 Medical food Market
6.5.1 Overview
6.5.2 Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 probiotics Market
6.6.1 Overview
6.6.2 Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 prebiotics Market
6.7.1 Overview
6.7.2 Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 drugs Market
6.8.1 Overview
6.8.2 Asia Pacific Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
6.9 DIAGNOSTIC DEVICES Market
6.9.1 Overview
6.9.2 Asia Pacific Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.10 SUPPLEMENTS Market
6.10.1 Overview
6.10.2 Asia Pacific Supplements Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. Asia Pacific human microbiome market Analysis – By disease
7.1 Overview
7.2 ASIA PACIFIC HUMAN microbiome MARKET, BY disease, 2017 & 2025 (%)
7.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
7.4 diabetes Market
7.4.1 Overview
7.4.2 Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CANCER Market
7.5.1 Overview
7.5.2 Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 AUTOIMMUNE DISORDERS Market
7.6.1 Overview
7.6.2 Asia Pacific Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.7 OBESITY Market
7.7.1 Overview
7.7.2 Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
7.8 MENTAL DISORDERS Market
7.8.1 Overview
7.8.2 Asia Pacific Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.9 Others Market
7.9.1 Overview
7.9.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. Asia Pacific human microbiome market Analysis – By application
8.1 Overview
8.2 ASIA PACIFIC Human microbiome MARKET, BY application, 2017 & 2025 (%)
8.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
8.4 Diagnostics Market
8.4.1 Overview
8.4.2 Asia Pacific Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 therapeutics Market
8.5.1 Overview
8.5.2 Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9. Asia Pacific Human microbiome Market Revenue and Forecasts to 2025
9.1 Overview
9.2 asia pacific Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.3 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.4 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
9.5 Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.6 Asia Pacific Human microbiome Market Revenue And Forecasts to 2025, By Country (%)
9.7 China Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.1 China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.7.3 China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.7.4 China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8 Japan Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.1 Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.8.3 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.8.4 Japan Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9 India Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.1 India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 India Human microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.9.3 India Human microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.9.4 India Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
PART 10. Human Microbiome Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Human Microbiome Market, 2015-2018
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.2 Product Launch & Approvals
10.3.3 Expansion
10.3.4 Patent and license
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.2 Acquisitions
10.4.3 Partnerships, Collaborations & Agreements
10.4.4 Joint Ventures
PART 11. Human microbiome Market–Key company profiles
11.1 ENTEROME
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MICROBIOME THERAPEUTICS, LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Rebiotix Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Yakult Honsha Co., Ltd.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Osel Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 Swot Analysis
11.5.6 Key Developments
11.6 Vedanta Biosciences, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Metabiomics Corporate
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Synthetic Biologics, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DuPont
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 BiomX
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
PART 12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
TABLE 1. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 3. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 4. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 5. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 6. Asia Pacific Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 7. China Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 8. China Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 9. China Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 10. Japan Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 11. Japan Human microbiome market Revenue And Forecasts to 2025, By disease (US$ Mn)
TABLE 12. Japan Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 13. India Human microbiome market Revenue And Forecasts to 2025, By Product (US$ Mn)
TABLE 14. India Human microbiome market Revenue And Forecasts to 2025, By Disease (US$ Mn)
TABLE 15. India Human microbiome market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 16. Recent Product Launches & Approvals in the Human Microbiome Market
TABLE 17. Recent EXPANSIONS in the Human Microbiome Market
TABLE 18. Patent and License Organic Growth Strategies in the Human Microbiome Market
TABLE 19. Recent Acquisitions in the Human Microbiome market
TABLE 20. Recent Partnerships & Collaborations in the Human Microbiome market
TABLE 21. Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market
TABLE 22. Glossary of Terms, Human microbiome market
LIST OF FIGURES
FIGURE 1. JApan Human microbiome market, Revenue (US$ Mn), 2018 & 2025
FIGURE 2. Asia Pacific human microbiome Market By product, Market Share (%), 2017
FIGURE 3. Asia Pacific Human microbiome Market By disease, Market Share (%), 2017
FIGURE 4. Asia Pacific Human microbiome Market By application, Market Share (%), 2017
FIGURE 5. Human microbiome market Segmentation
FIGURE 6. Asia pacific PEST Analysis
FIGURE 7. human microbiome market impact analysis of drivers & Restraints
FIGURE 8. Asia Pacific Human microbiome market – Revenue Forecasts and Analysis – 2017- 2025
FIGURE 9. Asia Pacific Human microbiome market, By Product, 2017 & 2025 (%)
FIGURE 10. Asia Pacific foods Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 11. Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 12. Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 13. Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. Asia Pacific drugs Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. Asia Pacific DIAGNOSTIC DEVICES Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. Asia Pacific SUPPLEMENTS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. Asia PACIFIC HUMAN microbiome market By disease, 2017 & 2025 (%)
FIGURE 18. Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 20. Asia Pacific Autoimmune Diseases Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 22. Asia Pacific MENTAL DISORDERS Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 24. Asia Pacific Human microbiome market By application, 2017 & 2025 (%)
FIGURE 25. Asia Pacific diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 26. Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. Asia Pacific human microbiome Market REVENUE, by Country, 2017 (US$ MN)
FIGURE 28. asia pacific Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 29. Asia Pacific Human microbiome Market Revenue And Forecasts to 2025, By Country (%)
FIGURE 30. China Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 31. Japan Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 32. India Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 33. Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 34. Organic Growth Strategies in the Human Microbiome Market, 2015-2018
FIGURE 35. Inorganic Growth Strategies in the HUMAN MICROBIOME Market, 2015-2018
The List of Companies
- Enterome
- MicroBiome Therapeutics, LLC
- Rebiotix Inc.
- Yakult Honsha Co., Ltd.
- Osel Inc.
- Vedanta Biosciences, Inc.
- Metabiomics Corporate
- Synthetic Biologics, Inc.
- DuPont
- BiomX Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.